Former FDA head takes place on Pfizer board

Pfizer has appointed former US Food and Drug Administration (FDA) commissioner Scott Gottlieb to its board.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

More on this story

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

More on this story

Big Pharma

Pfizer off-patent division to merge with Mylan

29 July 2019 Pfizer is to merge its off-patent drug business Upjohn with Mylan, in a deal that will see Pfizer shareholders own 57% of the new company.

Americas

National Cancer Institute’s director named as acting FDA chief

13 March 2019 The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.

Americas

FDA chief Gottlieb resigns after nearly two years

6 March 2019 Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?

Former FDA head takes place on Pfizer board

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features